General Equity Doctors Diagnostic Imaging L P is categorized under In Vitro Diagnostics in Dallas, TX and active since 2001.
General Equity Doctors Diagnostic Imaging L P was established in 2001, and today employs 1 to 4, earning $100.000 to $499.999 per year. This is a In Vitro Diagnostics business, which does work in the B2B market, and is classified as a In Vitro Diagnostics, under code number 325413 by the NAICS.
If you are seeking more information, feel free to contact Larry Nelson at the company’s single location by writing to 7515 Greenville Avenue # 200, Dallas, Texas TX 75231 or by phoning (972) 759-5140. You can also visit this business on Facebook by going to their profile page at Facebook or on find them on Twitter.
Business Name: | General Equity Doctors Diagnostic Imaging L P |
Contact Person: | Larry Nelson |
Address: | 7515 Greenville Avenue # 200, Dallas, Texas 75231 |
Phone Number: | (972) 759-5140 |
Annual Revenue (USD): | $100.000 to $499.999 |
Founded: | 2001 |
Location Type: | Single Location |
Employee Number: | 1 to 4 |
Business Type: | B2B (Business to Business) |
Business Category: | In Vitro Diagnostics |
SIC Code: | 2835 |
NAICS Code: | 325413 |
Share This Business: |
General Equity Doctors Diagnostic Imaging L P was started in 2001 to provide professional In Vitro Diagnostics under the SIC code 2835 and NAICS code 325413. Since its inception, the company has gone on to take a total of 1 to 4 personnel under its employment and has achieved earnings of $100.000 to $499.999 per annum.
Feel free to contact Larry Nelson for inquiries that concern General Equity Doctors Diagnostic Imaging L P by calling the company number (972) 759-5140, as your correspondence is most welcome. Additionally, the physical location of the single location of General Equity Doctors Diagnostic Imaging L P can be found at the coordinates as well as the street address 7515 Greenville Avenue # 200 in Dallas, Texas 75231.
For its online presence, you may visit General Equity Doctors Diagnostic Imaging L P’s website at and engage with its social media outlets through on Twitter and on Facebook.